TEVA Stock Ownership Activity

TEVA PHARMACEUTICAL-SP ADR 13F holders

2 value investing gurus have made changes to the TEVA PHARMACEUTICAL-SP ADR (TEVA) position according to the gurus' latest SEC quarterly report(s). The number of TEVA shares has been decreased by 2 super investor(s).

Which gurus or hedge funds are buying TEVA now?

According to the latest SEC filing(s) TEVA PHARMACEUTICAL-SP ADR (TEVA) has not been purchased by any super investor.

To see more about who is investing in TEVA PHARMACEUTICAL-SP ADR (TEVA), please go to the TEVA ownership page.

History
Name
Company
%
Activity
Share
Change
% change to
Portfolio
% of
Portfolio
2013 Q3 (2 results)
Ronald Muhlenkamp
Muhlenkamp & Co
+0.19%
+325
+0.00%
1.29%
David Abrams
Abrams Capital Management
-100.00%
-2,561,269
-7.86%
0.00%
AVG reported price*: $37.78
2013 Q2 (3 results)
David Abrams
Abrams Capital Management
buy
+2,561,269
+5.81%
0.00%
Ronald Muhlenkamp
Muhlenkamp & Co
buy
+169,660
+1.40%
1.40%
Ravenel Boykin Curry IV
Eagle Capital Management
buy
+22,400
+0.00%
0.00%
AVG reported price*: $39.20
5 of 104

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.